Pie Funds adds director and adviser
Pie Funds has completed its leadership team which includes an appointment to its investment committee.
Wednesday, June 7th 2023, 6:34AM
Pie Funds has rejigged its board following Ana-Marie Lockyer move from being a director and chair to becoming the chief executive.
Matt Blackwell is the new independent director and he will also sit on the investment committee as independent adviser to the board.
A new director appointment was signalled to replace Ana-Marie Lockyer as director and chair, following her move to CEO in December 2022. Roger Kerr has held the acting chair role since December and
Blackwell will transition to the chair following the annual meeting in September, replacing Roger Kerr who has been the acting chair since Lockyer became CEO in December.
He says “he is excited to be part of such a talented team and having been a client of Pie Funds for a number of years, admits he is looking forward to working with the team in the next stage of Pie’s evolution.”
Blackwell is a professional director specialising in investment markets and risk management. He began his career in banking holding corporate treasury, sales and trading roles at BNZ including the coverage of fund managers for interest rate derivatives.
He moved to BNZ's parent company, National Australia Bank (NAB) in Melbourne where he was responsible for the credit trading business in Australia, and then to NAB Hong Kong to run interest rate trading and structuring in the Asian region.
Blackwell spent nine years with Deutsche Bank Singapore in global roles, working with clients in Asia, New York and London including as managing director and co-head of Asian foreign exchange, fixed income and commodities sales and having responsibility for some of the bank’s largest hedge fund and sovereign wealth clients.
He returned to New Zealand in 2014, taking an equity position at OM Financial and was CEO from 2016 for six years until the completion of its sale to Jarden. He also took an equity and board position with Medi-Map NZ, a medtech startup, which was sold in 2023.
He has been a member of the New Zealand Markets Disciplinary Tribunal since 2017 as well as a member of the special division, and is also a company director for Auckland Thoroughbred Racing.
« FANZ's newest board member has a rich background | Strategi CEO moving on, COO in charge of day-to-day » |
Special Offers
Comments from our readers
No comments yet
Sign In to add your comment
Printable version | Email to a friend |